Evidence map›Paper›PMID 34642778›Full record

ArticleCancer immunology, immunotherapy : CII2022

The Crohn's-like lymphoid reaction density: a new artificial intelligence quantified prognostic immune index in colon cancer.

Minning Zhao, Su Yao, Zhenhui Li, Lin Wu, Zeyan Xu, Xipeng Pan, Huan Lin, Yao Xu, Shangqing Yang, Shenyan Zhang and 4 more

Open access · greenAbstract read
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Minning Zhao *The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Su Yao *Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Zhenhui Li *Department of Radiology, Yunnan Cancer Center, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Lin WuDepartment of Pathology, Yunnan Cancer Center, Yunnan Cancer Hospital, the Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Zeyan XuDepartment of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Xipeng PanDepartment of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Huan LinDepartment of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China.
Yao XuSchool of Bioengineering, Chongqing University, Chongqing, China.
Shangqing YangSchool of Life Science and Technology, Xidian University, Xian, China.
Shenyan ZhangDepartment of Pathology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Yong LiDepartment of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Ke ZhaoDepartment of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China. ksw2024@163.com.
Changhong LiangDepartment of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China. liangchanghong@gdph.org.cn.
Zaiyi LiuThe Second School of Clinical Medicine, Southern Medical University, Guangzhou, China. liuzaiyi@gdph.org.cn.ORCID http://orcid.org/0000-0003-3296-9759
Guangdong Academy of Medical Sciences · CNKunming Medical University · CNChongqing University · CNSun Yat-sen University · CNXidian University · CN

Funding

High-level Hospital Construction Project DFJH201805High-level Hospital Construction Project DFJH201914National Key Resesrch and Development program of China 2017YFC1309102National Natural Science Foundation of China 82001986National Natural Science Foundation of China 82071892National Science Fund for Distinguished Young Scholars 81925023
6 · The paper itself

Abstract

backgroundThe Crohn's-like lymphoid reaction (CLR) is manifested as peritumoral lymphocytes aggregation in colon cancer, which is a major component of the host immune response to cancer. However, the lack of a unified and objective CLR evaluation standard limits its clinical application. We, therefore, developed a deep learning model for the fully automated CLR density quantification on routine hematoxylin and eosin (HE)-stained whole-slide images (WSIs) and further investigated its prognostic validity for patient stratification.

methodsThe CLR density was calculated by using a deep learning method on HE-stained WSIs. A training (N = 279) and a validation (N = 194) cohorts were used to evaluate the prognostic value of CLR density for overall survival (OS).

resultThe fully automated quantified CLR density was an independent prognostic factor, with high CLR density associated with increased OS in the discovery (HR 0.58, 95% CI 0.38-0.89, P = 0.012) and validation cohort (0.45, 0.23-0.88, 0.020). Integrating CLR density into a Cox model with other risk factors showed improved prognostic capability.

conclusionWe developed a new immune indicator (CLR density) quantified by a deep learning method to evaluate the lymphocytes aggregation in colon cancer. The CLR density was demonstrated its predictive value for OS in two independent cohorts. This approach allows for the objective and standardized quantification while reducing pathologists' workload. Therefore, this fully automated standardized method of CLR evaluation had potential clinical value.

Indexed as

Colonic NeoplasmsColorectal NeoplasmsArtificial IntelligenceHumansPrognosisProportional Hazards ModelsArtificial intelligenceColon cancerCrohn’s-like lymphoid reactionDeep learningLymphocytes aggregationOverall survival

Identifiers

PMID34642778
PMCPMC10992499
OpenAlexW3207129596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.